Amphetamine, but not methylphenidate, increases ethanol intake in adolescent male, but not in female, rats by Ruiz, Paul et al.
Brain and Behavior. 2018;e00939.	 	 	 | 	1 of 13
https://doi.org/10.1002/brb3.939
wileyonlinelibrary.com/journal/brb3
1  | INTRODUC TION
Worldwide, up to 5% of children and youth up to 18 years old are di-
agnosed with attention- deficit hyperactivity disorder (ADHD). This 
syndrome affects attention and school performance, activity levels, 
and is mostly treated with psychostimulants [e.g., d- amphetamine 
(AMPH) and methylphenidate (MPH)].
Despite recent studies suggesting the relative advantages of the 
use of stimulants as treatment for ADHD (Dalsgaard, Kvist, Leckman, 
Nielsen, & Simonsen, 2014), yet see earlier work by Lambert and 
Hartsough (1998), there is still an ongoing discussion about the 
effects of these drugs upon the patient’s risk of development of 
ethanol- related or other drug- related problems (Quinn et al., 2017). 
Late infancy (Pilatti, Godoy, Brussino, & Pautassi, 2013) and adoles-
cence (Pilatti, Read, & Pautassi, 2017) are developmental stages in 
which ethanol initiation normatively occurs and in which treatments 
that alter developmental trajectories of dopamine (DA) or other 
transmitter systems are likely to facilitate the escalation toward 
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Abstract
Introduction: There has been an increasing interest in analyzing the interactions be-
tween stimulants and ethanol during childhood and adolescence. Stimulants are used 
to treat attention- deficit hyperactivity disorder (ADHD) in these developmental 
stages, during which ethanol initiation and escalation often occur.
Methods: This study assessed the effects of repeated d- amphetamine (AMPH) or 
methylphenidate (MPH) treatment during adolescence [male and female Wistar rats, 
between postnatal day (PD) 28 to PD34, approximately] on the initiation of ethanol 
intake during a later section of adolescence (PD35 to PD40).
Results: Amphetamine and MPH exerted reliable acute motor stimulant effects, but 
there was no indication of sensitized motor or anxiety responses. MPH did not affect 
dopamine (DA) levels, whereas AMPH significantly reduced insular levels of DA in 
both sexes and norepinephrine levels in females only. Repeated treatment with 
AMPH, but not with MPH, enhanced ethanol intake during late adolescence in male, 
but not in female, rats.
Conclusion: A short treatment with AMPH during adolescence significantly altered 
DA levels in the insula, both in male and females, and significantly enhanced ethanol 
intake in males. The present results suggest that, in adolescent males, a very brief 
history of AMPH exposure can facilitate the initiation of ethanol intake.
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ethanol abuse or dependence (Pascual, Boix, Felipo, & Guerri, 2009). 
AMPH and MPH exert their action by increasing the synaptic levels 
of catecholamine transmitters, such as DA, either by increasing their 
release from or by inhibiting their reuptake into neurons.
In other words, a significant fraction of children and adolescent 
are concurrently or, more likely, sequentially exposed to stimulants 
and ethanol and more information is needed on how repeated ex-
posure to the former drugs affect the initiation of ethanol intake 
and preference (Mannuzza et al., 2008). Specifically, treatment with 
stimulants begins at around age 9–11 (Mannuzza et al., 2008), ap-
proximately, whereas age of ethanol initiation (i.e., first intake of 
a full standard drink) takes place between 14 and 16 years of age 
(Pilatti et al., 2017).
Animal studies suggest that repeated stimulant exposure may 
sensitize the neural and behavioral response to subsequent drug 
challenges, enhancing the reinforcing effects of these drugs and 
rendering the individual at risk for drug addiction (Mannuzza et al., 
2008; Schenk & Davidson, 1998). The sensitization induced by drugs 
of abuse, which is thought to reflect the transition from a nonad-
dicted to an addicted state, can occur at many levels, yet it has been 
most often analyzed by assessing the progressive increase in drug- 
induced motor stimulation that results from repeated drug exposure 
(Camarini & Pautassi, 2016). It should be noted, however, that some 
have suggested that a low level of response to the stimulant effects 
of ethanol or psychostimulants can also be a risk factor for drug ad-
diction disorders. A blunted response to ethanol may promote eth-
anol initiation or escalation (Quinn & Fromme, 2011; Schuckit et al., 
2000), for instance by facilitating binge drinking to reach a preferred 
level of intoxication (Schuckit, 2009). Furthermore, rats classified as 
low cocaine responders—based on their acute locomotor response 
to cocaine—exhibited greater cocaine- induced behavioral sensiti-
zation and greater operant responding for cocaine (Mandt, Schenk, 
Zahniser, & Allen, 2008).
It is difficult to define the boundaries of adolescence in rodents, 
yet a seminal review defined the period as encompassing postnatal 
days 28–42 [PDs 28–42; (Spear, 2000)]. This conservative definition 
is still used [see (McClintick et al., 2015)], yet further refinements 
have been made, with some denominating the PD 28–42 stage as 
mid- adolescence or early adolescence (Doremus- Fitzwater & Spear, 
2016; Karanikas, Lu, & Richardson, 2013), the preceding week (PDs 
21–28, sometimes up to PD34) as juvenile period, and the period be-
tween PD46 and PD 59 as late adolescence (Burke & Miczek, 2014) 
or emerging adulthood.
The few preclinical studies that, to our knowledge, dealt with 
the relationship between ADHD treatments and subsequent eth-
anol intake have yielded inconsistent results, and none conducted 
both events within the adolescent stage of development. Gill, 
Chappell, Beveridge, Porrino, and Weiner (2014) found greater 
drinking of sweetened ethanol after a lengthy MPH treatment in 
young adult, male, rats reared under environmental enrichment, 
but not in those reared under standard or isolated housing con-
ditions. Earlier work (Vendruscolo, Izídio, Takahashi, & Ramos, 
2008) found greater ethanol intake in adult female, but not in 
male, spontaneously hypertensive (SHR) rats that had been given 
MPH (2.0 mg/kg, twice daily during 16 days) during adolescence. 
A lack of effect of MPH [treatment during PDs 21–35] upon eth-
anol consumption of SHR rats was reported by Soeters, Howells, 
and Russell (2008). These studies have the caveats of either testing 
ethanol intake only in one sex, with ethanol mixed in sugar or they 
conducted the administration of the stimulant in one developmen-
tal stage (i.e., adolescence), yet tested for ethanol intake at other 
stage (i.e., adulthood). These “serial” designs are valuable to un-
derstand the lingering, persistent consequences of early stimulant 
treatment, yet they do not mirror well the type of exposure that 
takes place in humans. As described, age at initiation of treatment 
for ADHD precedes that of ethanol initiation, yet both take place 
well before adulthood and within the stages of late infancy and 
adolescence.
More work is needed to ascertain ethanol use liability in ado-
lescents treated with stimulants. Moreover, sex differences should 
be more carefully pursued. Males and females differentially react to 
drugs (Wille- Bille et al., 2017), yet despite the increasing awareness 
of these differences and the explicit suggestion to have same- sex 
representativeness (McCullough et al., 2014), women/female are 
still a neglected group in epidemiological and preclinical research. 
Last but not least, repeated MPH exposure and AMPH exposure are 
also used to model manic and bipolar conditions in laboratory ani-
mals (Frey et al., 2006), and there is some evidence suggesting ex-
acerbated ethanol consumption in individuals with bipolar disorders 
(Strakowski & DelBello, 2000).
The main aim of this study was to assess, in Wistar male and 
female adolescent rats, the effects of repeated MPH or AMPH treat-
ment (between PD28 to PD34, approximately) on the acquisition of 
voluntary ethanol drinking during PD36 to PD42. Motor activity pat-
terns and anxiety response [a promoter of ethanol drinking in ado-
lescent rats (Acevedo, Fabio, Fernandez, & Pautassi, 2016)] induced 
by the repeated drug treatment were also assessed.
Specifically, in Experiment 1 of this study, the rats received 
daily administration of MPH or vehicle, during 4 days, with motor 
activity measured after each administration and then were tested 
for ethanol intake in an intermittent- access intake protocol. MPH 
did not induce sensitization to the motor effects of the drug nor 
significantly affected ethanol intake patterns. In Experiment 2, we 
analyzed ethanol intake in male and female adolescents after an 
induction- expression sensitization protocol with AMPH. In this 
protocol, animals are given repeated treatment with a drug or its 
vehicle followed by a challenge test, in which all receive a lower 
dose of the drug than that used during training. The rationale is 
that the acute effect of the lower dose will be higher (i.e., sensi-
tized) in those with chronic exposure to the drug than in drug- 
naïve controls (Camarini & Pautassi, 2016; Kuczenski & Segal, 
2001).
We also measured insular levels of dopamine (DA) after MPH 
treatment, whereas DA, norepinephrine, and serotonin (5- HT) levels 
at the insular cortex were measured after AMPH treatment. DA, nor-
epinephrine, and 5- HT are implicated in the therapeutic effects of 
     |  3 of 13RUIZ et al.
MPH and AMPH (Kuczenski & Segal, 2001), yet sustained treatment 
with stimulants can induce neuroadaptive changes in these systems 
(Cryan, Hoyer, & Markou, 2003). These effects are found across sev-
eral brain areas including mesolimbic and mesocortical pathways. 
Based on previous studies, however, we decided to focus on the in-
sular cortex. We have recently observed that low levels of dopamine 
at the insula were associated, in adolescent Wistar rats, with height-
ened ethanol consumption (Ruiz, Calliari, & Pautassi, 2017). Also, 
Diaz Heijtz and Castellanos (2006) observed significantly greater 
insular c-fos expression after the administration of a D1 agonist, in 
spontaneously hypertensive rats (SHR, an animal model of ADHD) 
than in Wistar–Kyoto rats. Recently, adolescent rats treated with 
MPH exhibited reduced activity of the brain- derived neurotrophic 
factor and its associated TrkB receptor, at the insular cortex (Wetzell 
et al., 2014). Several studies propose that reduced activity of the in-
sular cortex plays a key role in the transition from stimulant use to 
stimulant use disorder (Stewart, Butt, May, Tapert, & Paulus, 2017) 
and in subsequent relapse (Gowin et al., 2014; Venniro et al., 2017) 
into stimulant use.
2  | GENER AL METHODS
2.1 | Experimental designs
Experiment 1 employed 36 males and 34 females in a 2 (sex) × 2 
[drug treatment: 0.0 (vehicle control) or 10.0 mg/kg MPH, once daily 
for 4 days] factorial design. Experiment 2a employed 72 adoles-
cents, distributed in a 2 (sex) × 2 [treatment: 0.0 (vehicle control) or 
4.0 mg/kg AMPH, once daily for 5 days] factorial design. Experiment 
2b employed 20 animals, evenly distributed in the design described 
for Experiment 2a.
2.2 | Subjects
The rats (strain: Wistar; see Supporting Information for body weight 
data) were reared at the production vivarium of INIMEC- CONICET- 
Universidad Nacional de Córdoba (UNC; Córdoba, Argentina), a 
provider of specific, pathogen- free, animals. They were transferred 
upon weaning (PD 21) to the animal maintenance room of our labo-
ratory. We did not explicitly measure signs of puberty (e.g., vaginal 
opening or preputial skinfold separation) in our animals, yet histori-
cal observations from our colony indicates that puberty onset in 
these rats is, in agreement with prior literature (Spear, 2015), be-
tween PDs 36–40 for males and about 4–8 days earlier in females. 
Lighting conditions in both facilities are kept in a 12 hr on—12 off 
cycle (on at 0700), with a temperature of 20–22°C and a humidity 
of 45%, approximately. Breeding and experimental procedures fol-
lowed the Declaration of Helsinki, were approved by the Ministry 
of Animal Care of INIMEC- CONICET, and were in accordance with 
the Guide for the Care and Use of Laboratory Animals of the NIH 
(National- Research- Council, 1996). No more than one rat per litter 
was assigned to a given group. Unless stated otherwise, the animals 
were kept in same- sex groups of four.
2.3 | Drugs
Methylphenidate (Europharma, Uruguay) and AMPH (Sigma 
Aldrich, Uruguay) were chronically administered i.p., at a dose 
of 10.0 or 4.0 mg/kg, respectively (free base; vehicle: 0.9% sa-
line; injection volume: 0.01 ml/g) and expressed as mg of drug 
administered by a thousand grams (i.e., a kg) of body weight. Drug 
dosage was chosen based on extensive previous literature [MPH: 
(Gaytan,	Ghelani,	Martin,	Swann,	&	Dafny,	1996;	Jones	&	Dafny,	
2013); AMPH: (Kameda et al., 2011)]. Our aim was to test whether 
repeated treatment with these doses, which are commonly used in 
the literature of animal models of ADHD, would alter subsequent 
ethanol self- administration during adolescence and assess poten-
tial behavioral and neurochemical correlates of this effect. More 
in detail, the MPH dose employed is in the upper range of doses 
employed in animal models of ADHD (Karim, Reyes- Vazquez, & 
Dafny, 2017; Venkataraman, Claussen, & Dafny, 2017); and doses 
equal or lower than 10.0 mg/kg MPH have been found to evoke 
changes in MPH- induced motor activity (i.e., behavioral sensitiza-
tion or tolerance; Chong, Claussen, & Dafny, 2012; Frolov, Reyes- 
Vasquez, & Dafny, 2015; Gaytan, Nason, Alagugurusamy, Swann, 
& Dafny, 2000; Gaytan, Yang, Swann, & Dafny, 2000). Similarly, 
we employed a dose of AMPH that has been repeatedly employed 
in the assessment of AMPH- induced behavioral sensitization and 
has been shown to yield this phenomenon in adolescent mice 
(Kameda et al., 2011).
2.4 | Assessment of drug- induced motor 
activity and anxiety response
All animals were given an habituation session (PD26 or 27) to the 
open field (OF), in which they were administered saline and placed 
for 10 min in an open field. In the following days, the animals were 
placed in the dimly lit (circa 50 lux, 60 × 60 × 60 cm) OF, made of 
Plexiglas and equipped with photocell beams, 40 min postadmin-
istration of the corresponding drug treatment (i.e., vehicle, MPH, 
or AMPH). Beam breaks were transmitted to a monitoring system 
(ITCOMM, Córdoba, Argentina) that delivered a measure of dis-
tance traveled (cm).The rats were withdrawn from the OF after 
10 min. The postadministration interval in which motor activity 
was assessed was chosen based on work by Gaytan et al. (1996).
Anxiety response was assessed via a LDB test routinely used 
in our laboratory (Wille- Bille et al., 2017). This assay took place 
at PD35, after termination of the stimulant treatment, and used a 
square- shaped apparatus composed of two sections, one black and 
lacking illumination (i.e., 0 lux), whereas the other was white and 
brightly lit (300 lux). Both sections were connected by an opening 
at floor level. The test lasted for 5 min and began by gently plac-
ing the animal in the white sector, opposed to the door opening. 
The test was videotaped for subsequent measurement of time 
spent in the white compartment and number of transfer between 
compartments.
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2.5 | Ethanol intake protocol
We employed a standardized (Wille- Bille et al., 2017), intermittent- 
access intake protocol, composed by three intake sessions beginning 
at 900AM of PD35, PD37, and PD39 (length: 24 hr per session). At 
the beginning of each intake session, the animals were weighed and 
individually transferred to a clean cage lined with pine shavings and 
equipped with two 100 ml bottles and ad libitum food. They were 
exposed to two bottles, one contained water and the other con-
tained 5% ethanol. Each bottle was weighed before and after each 
session to provide an index of fluid intake. The following variables 
were calculated: grams per kilogram (g/kg) of ethanol ingested, per-
centage of ethanol intake preference [(ethanol intake/overall liquid 
intake) × 100], and the overall fluid intake [milliliters of fluid per 
100 grams of body weight (ml/100 g)]. We took care of leakage by 
reading the pre- and postsession levels of two bottles, placed in an 
empty cage. In- between sessions, the rats were housed in same- sex 
couples and had unrestricted access to food and water.
The rationale for using 5% ethanol is that this concentration is 
similar to that of the beverages usually consumed by adolescents. A 
study (Pinsky, Zaleski, Laranjeira, & Caetano, 2010) found that more 
than half of the ethanol ingested by adolescents is derived from 
beer, a drink containing 3%–8% ethanol. Sixty- seven percent of ad-
olescents aged 18–20 years who incurred in binge drinking in the 
United States also reported beer as their beverage of choice (Naimi, 
Brewer, Miller, Okoro, & Mehrotra, 2007). It also has been reported 
that ethanol- naïve, adolescent Wistar, rats drank very little ethanol 
when	given	at	concentrations	≥6%.	In	previous	studies,	we	overcame	
this by exposing the adolescents to substantial water deprivation or 
by mixing the drug with sucrose (Ponce, Pautassi, Spear, & Molina, 
2011). In this study, however, we deemed better to avoid the caveats 
associated with the caloric surplus of sucrose and the stress induced 
by dehydration.
2.6 | Assessment of dopamine, 
serotonin, and norepinephrine
We followed a procedure similar to that described in Ruiz et al. 
(2017). Briefly, the animals were killed by decapitation. The enceph-
alous was quickly obtained, and the insular cortex was dissected 
following the technique described by Aleksandrov and Fedorova 
(2003).	The	tissue	was	kept	frozen	at	−80°C	until	 further	process-
ing. The samples were then weighed and sonicated in 1 ml of per-
chloric acid (0.1 mol/L). The resulting solution was centrifuged to 
obtain a supernatant. Those samples were injected into an HPLC 
system (PM- 80 BAS, West Lafayette, IN, USA) equipped with a C18 
column and a LC- 4C BAS electrochemical detector. The flow was 
kept at 1 ml/min, and the mobile phase was composed by 0.15 mol/L 
acetic acid, 0.6 mol/L octyl sulfate of sodium, acetonitrile (4%), and 
tetrahydrofuran (1.6%, PH 3). Data are expressed as ng/g. These 
measurements were conducted at the Neurochemistry Laboratory 
of the Instituto de Investigaciones Biológicas Clemente Estable 
(Montevideo, Uruguay).
2.7 | Specific methods of Experiment 1
All the rats (n = 70, 36 males and 34 females) received daily adminis-
tration of MPH or vehicle, during four days (PDs 28–31).
Thirty- eight of these subjects (n = 10 in the male groups treated 
with MPH or vehicle, n = 9 in the female groups) were assessed for 
motor activity after each administration and subsequently, on PDs 
35, 37, and 39, were tested for ethanol intake. The remaining 32 
rats (n = 8 in each group) were tested for anxiety response in the 
LDB test on PD35. Of these rats tested in the LDB, 22 (11 male, 
11 female, n = 7 in MPH- treated groups, n = 4 in vehicle- treated 
groups) were sampled on PD36 for DA concentration at the insular 
cortex.
2.8 | Specific methods of Experiment 2
The 72 male and female adolescents used in Experiment 2a were 
treated daily with AMPH or vehicle during 5 days (PDs 27–31). On 
PD33, they were all challenged with a lower dose [2.0 mg/kg, based 
on work by Adriani, Chiarotti, and Laviola (1998)] than that used dur-
ing the induction phase. Forty of these animals (n = 10 per group) 
were assessed for motor activity after each administration and sub-
sequently, on PDs 35, 37, and 39, were tested for ethanol intake. The 
remaining 32 rats (8 in each group) received AMPH or vehicle, yet 
were not tested for motor activity in the OF nor for ethanol intake. 
Instead, they were tested in a LDB test on PD35.
Experiment 2b employed 10 adolescent males and 10 adolescent 
females. Five animals of each sex were treated daily with AMPH and 
the rest were given vehicle. On PD36, these animals were submitted 
to the assays for measurement of catecholamine levels. In addition to 
DA, norepinephrine and 5- HT (transmitters known to be significantly 
involved in the regulation of ethanol intake) were also measured.
2.9 | Data analysis
Body weight (across experiments, recorded prior to each motor 
activity session or prior to the intake test sessions), distance trave-
led in the OF (cm), absolute ethanol intake (g/kg), percent ethanol 
preference, and overall fluid intake (ml/100 g of body weight) dur-
ing the intake sessions were analyzed by repeated- measures analy-
ses of variance (ANOVA). Depending on the experiment, sex, drug 
treatment during the repeated treatment, and drug treatment at 
the challenge served as between- subjects factors. Session was the 
within- subjects factor. Across experiments, the ANOVAs for body 
weight scores indicated that males were heavier than females and 
that this pattern was significantly similar across MPH- , AMPH- , or 
vehicle- treated rats. Body weights (mean ± SEM) across experiments 
are provided as Supporting Information in the online version of the 
article.
Each behavior measured in the LDB (Experiment 1 and 2a) and 
the levels of DA, norepinephrine, and 5- HT were independently ana-
lyzed using independent factorial ANOVAs, with sex and drug treat-
ment as independent factors.
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Tukey’s post hoc test (α = 0.05) was used to analyze significant 
main effects and interactions comprising “between” factors, and 
Cohen’s partial eta squared (η²p) was used to calculate effect sizes. 
Planned comparisons were used to analyze significant between fac-
tor × within factor interactions. The rationale for this distinction is 
that there is a lack of appropriate post hoc tests to analyze interac-
tions that involve both between- subjects and within- subjects fac-
tors (Winer, Brown, & Michels, 1991). Please note that, given the 
difficulty of illustrating significant main effects or significant inter-
actions that span several conditions and groups, some of the signifi-
cant differences have not been presented in the figures (via pounds 
or other signs). In those instances, however, a description of these 
significant differences can be found in each figure legend.
In animals given AMPH or MPH- repeated treatment we con-
ducted, separately for each sex, Pearson correlations between eth-
anol intake scores (g/kg ingested each testing day and mean g/kg 
ingested across days) and the percentage of change in distance trav-
eled in the last day of treatment relative to the first day of treatment.
All statistical analyses were conducted using the software 
Statistica 6.0 (STATISTICA, RRID:SCR_014213).
3  | RESULTS
3.1 | Experiment 1
The analysis for distance traveled across sessions revealed a sig-
nificant main effect of treatment, F1,34 = 28.40, p < .001, η²p = .46. 
As shown in Figure 1, MPH- treated rats exhibited greater distance 
traveled than vehicle- treated counterparts and this stimulant effect 
of MPH was similar in males and females and across days of testing.
The ANOVA for ethanol intake (g/kg, upper panel of Figure 2) 
yielded a significant interaction between drug treatment and session, 
F2,68 = 3.18, p < .05, η²p = .19. The post hoc tests conducted within 
each treatment indicated that MPH- treated, but not vehicle- treated, 
rats exhibited a significant decrease in g/kg ethanol ingested from 
the first to the second intake session. No significant between- group 
difference was observed, however, when contrasting, via the post 
hoc tests, MPH- control and vehicle- control counterparts, at any day 
of testing.
The ANOVA for percent preference only yielded a significant 
main effect of day, with significantly lower ethanol consumption 
in the second than in the first or third session. These results are 
depicted in the lower section of Figure 2. The ANOVA for overall 
liquid consumption scores (see descriptive statistics in Supporting 
Information) revealed a significant main effect of session: F2,68 = 5.54, 
p < .01, η²p = .14. The post hoc tests revealed greater overall liquid 
intake in the first than in the second or third sessions.
The Pearson correlations indicated the lack of significant associ-
ations between the percentage of change in MPH- induced distance 
traveled (i.e., PD31 scores relative to PD28 scores) and ethanol in-
take scores.
The ANOVA for number of transfers between compartments 
(LDB test) and for time spent in the white compartment (see Table 1) 
revealed significant main effect of sex (F1,28 = 7.29, p < .05, η²p = .20 
and F1,28 = 6.32, p < .05, η²p = .64, for each variable, respectively). 
The post hoc tests indicated that both behaviors were significantly 
greater in females than in males. The ANOVA of the dopamine con-
centration at the insula (see Table 1) yielded no significant main ef-
fect or significant interactions.
3.2 | Experiment 2
The analysis of distance traveled (see Figure 3) revealed significant 
main effects of treatment and days (F1,35 = 26.11, p < .001, η²p = .42 
and F5,175 = 13.02, p < .001, η²p = .27), and a significant treat-
ment × days interaction (F5,175 = 9.86, p < .001, η²p = .22). The post 
hoc tests indicated that distance traveled was significantly greater in 
AMPH versus vehicle- treated rats in all but the last testing session.
The ANOVA for gram per kilogram of ethanol ingested yielded 
a significant main effect of AMPH treatment (F1,35 = 4.19, p < .05, 
η²p = .11) and a significant interaction between AMPH treatment 
and sex (F1,35 = 4.60, p < .05, η²p = .12). The ANOVA for percent 
preference also revealed a significant AMPH treatment × sex inter-
action (F1,35 = 6.43, p < .05, η²p = .15). The post hoc tests conducted 
after the significant interaction yielded similar results: AMPH- 
treated male, but not female, rats exhibited significantly greater eth-
anol intake (g/kg ingested) and significantly greater ethanol percent 
preference than vehicle- treated counterparts. These results are in 
Figure 4.
The ANOVA for overall liquid consumption scores (data not 
shown) yielded a significant main effect of session: F2,66 = 38.50, 
p < .01, η²p = .54. The post hoc tests revealed greater overall 
F IGURE  1 Distance traveled (in centimeters) in the open field 
test in Experiment 1 in male and female Wistar rats as a function 
of days of assessment (1–4, which correspond to postnatal days 
28–31) and methylphenidate (MPH) dose administered before the 
test [0.0 (vehicle) or 10.0 mg/kg). The statistical analysis revealed 
that MPH- treated rats exhibited greater distance traveled than 
vehicle- treated counterparts, and this stimulant effect of MPH 
was similar in males and females and across days of testing. These 
significant differences are indicated by the asterisks. The data are 
expressed as mean ± SEM
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consumption, which was not affected by AMPH treatment or sex, in 
the second than in the first or third sessions. There was no significant 
correlation between the percentage of change in AMPH- induced 
distance traveled (PD32 relative to PD28) and ethanol intake scores.
The ANOVA for number of transfers between compartments 
(LDB test, see Table 1) only yielded a significant main effect of sex 
(F1,28 = 8.87, p < .01, η²p = .24), with the post hoc tests revealing 
significantly greater frequency of this behavior in females than in 
males. The ANOVA for time spent in the white compartment did not 
reveal significant min effects nor significant interactions.
The ANOVA for 5- HT levels did not reveal significant main ef-
fects or significant interactions. The ANOVA for norepinephrine lev-
els indicated a significant sex × treatment interaction (F1,16 = 31.90, 
p < .01, η²p = .66). The post hoc tests indicated that females, but not 
males, treated with AMPH exhibited reduced norepinephrine levels 
than same- sex, vehicle- treated controls. The ANOVA for DA levels, 
in turn, revealed a significant main effect of treatment (F1,16 = 4.81, 
p < .05, η²p = .23). The post hoc tests revealed AMPH treatment sig-
nificantly reduced insular levels of DA in both. Mean ± SEM (ng/ml) 
DA, 5- HT, and norepinephrine levels can be found in Table 1.
4  | DISCUSSION
The main new finding of the present study is that treatment with 
AMPH, but not with MPH, enhanced ethanol intake during late ad-
olescence, in male Wistar rats. More in detail, the males that had 
been exposed to AMPH had a mean average ethanol intake slightly 
below 5.5 g kg−1 24 hr−1, whereas control males drank around 
3.0 g kg−1 24 hr−1. AMPH pre- exposed males also exhibited, when 
compared to peer counterparts, a twofold increase in preference for 
ethanol (70% vs. 35%, respectively) versus water. The significant, 
AMPH- induced, increase in ethanol intake was specific for ethanol 
and did not generalize to the total quantity of fluids consumed. On 
F IGURE  2  (a–d) Mean ethanol intake (g/kg) (a) and percent preference (c) in male and female Wistar rats as a function of 
methylphenidate (MPH) dose administered on postnatal days 28–31, during sessions (i.e., days of assessment) 1, 2, and 3 of the intake 
protocol (Experiment 1). Two- bottle intake sessions (5% ethanol vs. plain water) were conducted on Monday, Wednesday, and Friday 
(session length: 24 hr), beginning on postnatal day 35 (PD35) and ending on PD40. The data are expressed as mean ± SEM. (b, d) Same as (a, 
c), collapsed across the three testing sessions. The statistical analysis revealed no significant difference between MPH- control and vehicle- 
control counterparts, at any day of test. Please refer to the text for a full account of the statistical analyses
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the other hand, drinking of ethanol in the females was not affected 
by AMPH treatment and MPH was mostly devoid of a modulatory 
effect upon ethanol ingestion in either sex.
There are few studies that assessed the effects of stimulant treat-
ment during adolescence on subsequent ethanol consumption, and 
to our knowledge, this is the first that conducted both events (stimu-
lant treatment and measures of ethanol intake) within the time frame 
of adolescence. The biggest novelty of the present work is that it 
shows that even a very short treatment with AMPH during early ad-
olescence can render male adolescents susceptible for greater etha-
nol intake. This is important because an early age of onset of ethanol 
consumption or an early age of first drunkenness rank among the 
best predictors of subsequent development of ethanol dependence 
(Pilatti, Caneto, Garimaldi, Vera Bdel, & Pautassi, 2014). As a com-
parison, other work (Gill et al., 2014) found heightened drinking of 
sweetened ethanol after MPH treatment in young adult rats, yet 
this effect was observed only in rats given environmental enrich-
ment housing conditions and after three weeks of treatment with 
the stimulant (8 mg kg−1 day−1 for 21 days, delivered via an osmotic 
pump). Also important is a study (Crowley, Cody, Davis, Lovinger, & 
Mateo,	2014)	 in	which	male	C57Bl/6J	mice	were	exposed	to	MPH	
(3–6 mg kg−1 day−1, dissolved in their drinking water bottle) through-
out adolescence (PDs 30–60). This treatment resulted in increased 
DA clearance at adulthood and a blunted response to the motor- 
activating effects of ethanol. Despite these neural and behavioral 
effects, no significant differences in ethanol drinking (tested across 
a wide range of concentrations: 3%–20%) were observed between 
MPH- treated and control mice (Crowley et al., 2014).T
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F IGURE  3 Distance traveled (in centimeters) in the open field 
test in Experiment 2a in male and female Wistar rats as a function 
of days of assessment (1–5, which correspond to postnatal days 
27, 28, 29, 30, and 31 and a challenge day on postnatal day 33) and 
amphetamine dose (AMPH) dose administered before each test 
[0.0 (vehicle) or 4.0 mg/kg). At the challenge, all the rats were given 
2.0 AMPH. The statistical analysis revealed that rats treated with 
AMPH, regardless sex, displayed significantly higher locomotor 
activity than those treated with vehicle during in days 1, 2, 3, 4, and 
5, but not during the challenge. These significant differences are 
indicated by the asterisks. The data are expressed as mean ± SEM
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A comparison can also be made between the present set of re-
sults and a study conducted, in adult female rats (Fahlke, Hansen, 
Engel, & Hard, 1994). These researchers gave AMPH or its vehicle 
daily, in an escalating scheme (from 1 to 9 mg kg−1 injection−1) and 
across a lengthy period (5- week). AMPH- treated rats exhibited en-
hanced intake of ethanol when tested three months after termina-
tion of the drug dosing. This work and our study concur in suggesting 
that repeated AMPH treatment can enhance subsequent ethanol in-
take. A main difference between the studies is that we failed to ob-
serve an AMPH- induced increase in ethanol intake in females. Major 
sources of explanation for this discrepant finding are the age tested, 
and the length and dose AMPH exposure.
What mechanisms led to the increased, AMPH- induced, ethanol 
intake found in Experiment 2? One possibility is that this repeated 
drug treatment yielded alterations in anxiety response or in risk- 
taking patterns, which promoted the ingestion of ethanol. These 
traits have been long considered phenotypes associated with pro-
pensity for ethanol intake. We have recently observed, for instance, 
that rats selectively bred for high ethanol intake during adolescence 
significantly avoided the white, potentially dangerous, chamber of a 
light–dark box (Fernandez et al., 2017); and in other study, we found 
that male rats reared under environmental enrichment exhibited 
both enhanced ethanol intake and behaviors indicative of greater 
risk- taking, when compared to counterparts reared under standard 
conditions (Berardo, Fabio, & Pautassi, 2016). In the present study, 
however, the patterns of exploration of the light–dark box were sim-
ilar in AMPH, MPH, and vehicle- treated rats. There was a sex effect, 
with the males displaying more inborn anxiety than the females, yet 
this was independent of the drug treatment.
Other possibility is that repeated AMPH treatment favors the 
development of behavioral sensitization, which in turn is associ-
ated with greater risk for exacerbated ethanol seeking and intake 
(Camarini & Pautassi, 2016). Support for this hypothesis comes from 
a study in which psychostimulant users exhibited heightened heart 
rate response to an ethanol challenge (Brunelle, Barrett, & Pihl, 2006). 
We analyzed sensitivity to the acute and chronic motor- activating 
F IGURE  4  (a–d) Mean ethanol intake (g/kg) (a) and percent preference (c) in male and female Wistar rats as a function of amphetamine 
dose (AMPH) dose administered at postnatal days 27–31 [0.0 (vehicle) or 4.0 mg/kg)], during sessions (i.e., days of assessment) 1, 2, and 3 
of the intake protocol (Exp. 2a). Two- bottle intake sessions (5% ethanol vs. plain water) were conducted on Monday, Wednesday, and Friday 
(session length: 24 hr), beginning on postnatal day 35 (PD35) and ending on PD40. The data are expressed as mean ± SEM. (b, d) Same as (a, 
c), collapsed across the three testing sessions. The statistical analysis revealed that, when compared to the pertinent vehicle- treated same- 
sex control, ethanol intake and preference were significantly enhanced across sessions in male, but not in female, rats treated with AMPH 
during the repeated treatment of postnatal days 27–31. This significant difference is indicated by the asterisks. Please refer to the text for a 
full account of the statistical analyses. The data are expressed as mean ± SEM
     |  9 of 13RUIZ et al.
effects of AMPH and MPH. Across the experiments, both AMPH 
and MPH exerted reliable acute motor stimulant effects. Yet, there 
was no indication of a gradual increase in this response. Similarly, the 
challenge test conducted in Experiment 2 failed to reveal a modula-
tory effect of the chronic treatment on the acute effect of the drug.
A first implication of the motor activity results is that there 
seems to be dissociation between the ability of these stimulant 
drugs to induce behavioral sensitization and their effects upon etha-
nol consumption: AMPH did not induce behavioral sensitization yet 
it significantly altered ethanol consumption in Experiment 2. Also, 
the lack of AMPH- induced or MPH- induced sensitization in our 
weaned, adolescent rats contrasts with results of studies with pre-
weanling rats. Duke, O’Neal, and McDougall (1997) observed signif-
icant behavioral sensitization in rats given 2.5 mg/kg AMPH, twice 
daily, during PDs 17–20. Other studies applied only one daily dose of 
AMPH (1.0, 2.5 or 5.0 mg/kg) or MPH (5.0, 10.0 or 15.0 or 20.0 mg/
kg) during PDs 17–20 (McDougall, Duke, Bolanos, & Crawford, 1994) 
or PDs 16–21 (McDougall, Collins, Karper, Watson, & Crawford, 
1999) and reported behavioral sensitization when tested 24 or 48 hr 
after the induction phase.
When the previous studies and the present study are put to-
gether, it seems that AMPH or MPH can induce motor behavioral 
sensitization during early ontogeny but not during adolescence. 
This is consistent with some, but not all, previous studies. A study 
(Kozanian, Gutierrez, Mohd- Yusof, & McDougall, 2012) found, albeit 
using stimulants other than AMPH or MPH, a sensitized response 
to the repeated administration of methamphetamine or cocaine in 
preweanling, but not in adolescent, rats. Conversely, adolescent but 
not adult mice exhibited greater motor activity to a challenge dose of 
AMPH (2.0 mg/kg), after a history of exposure to 10.0 mg/kg AMPH 
(Adriani et al., 1998). It has been suggested that the mechanisms re-
sponsible for the expression of long- term sensitization to psycho-
stimulants are just concluding maturation by the fourth week of rats’ 
postnatal life (Tirelli, Laviola, & Adriani, 2003), which could explain 
the variability in the reported results.
Administration of AMPH in adult rats often induces robust and 
long- lasting behavioral sensitization, which can also be observed 
a few days after the induction. Kuczenski and Segal (2001), for 
instance, gave adult Sprague–Dawley rats 0.1 or 0.25 mg/kg of 
AMPH, twice daily for 5 days. Treatment with the latter dose re-
sulted, 4 days later, in an augmented response to a 0.5 g/kg AMPH 
dose. The findings of other studies suggest, however, that our ado-
lescents could have shown behavioral sensitization if a shorter pro-
tocol had been used. Specifically, Kameda et al. (2011) found greater 
behavioral sensitization to AMPH in adolescent versus adult mice, as 
induced by a single injection of 4.0 mg/kg AMPH.
The effects of repeated MPH administration have not been con-
sistent, with behavioral sensitization reported by some (Gaytan, 
al- Rahim, Swann, & Dafny, 1997; Kuczenski & Segal, 2001; Sripada, 
Gaytan, Al- rahim, Swann, & Dafny, 1998) but not by other (Crawford, 
McDougall, Meier, Collins, & Watson, 1998; Izenwasser et al., 1999) 
studies. Most of these studies, however, employed a prolonged pre-
treatment or induction phase and were conducted in adult subjects 
only. The studies that assessed the effects of exposure to MPH 
during adolescence have also produced inconsistent results. MPH 
treatment during adolescence reduced subsequent CPP by cocaine 
(Andersen, Arvanitogiannis, Pliakas, LeBlanc, & Carlezon, 2002) yet 
enhanced cocaine- induced motor activity and self- administration 
(Brandon, Marinelli, Baker, & White, 2001). In another study, ado-
lescent male Wistar rats that had been given MPH (orally from PD 
27–33) did not exhibit behavioral sensitization when challenged 
with	either	MPH	(1.0	or	10.0	mg/kg)	or	nicotine	(0.4	mg/kg;	Justo,	
Carneiro- de- Oliveira, Delucia, Aizenstein, & Planeta, 2010).
The heightened ethanol intake, found in the males after AMPH 
treatment (Experiment 2a), was associated with a significant de-
crease in insular levels of DA (Experiment 2b). MPH, on the other 
hand, did not significantly alter insular levels of DA, and MPH- 
treated rats exhibited a significant decrease in absolute ethanol 
intake from the first to the second intake session (Experiment 1). 
These differences could relate to the fact that AMPH blocks the 
dopamine transporter (DAT) and the vesicular monoamine trans-
porter, whereas MPH only blocks DAT (Kuczenski & Segal, 1997). 
Is it possible to link the dopaminergic deficit to the greater etha-
nol intake? Ethanol intake in rats can be driven by DA deficits in 
the nucleus accumbens (Feltmann, Fredriksson, Wirf, Schilstrom, 
& Steensland, 2016), and ethanol craving in humans is associated 
with low levels of DA synthesis in the dorsal striatum (Heinz et al., 
2005). It also worth noting that the rationale for focusing our mea-
surements at the insula was that adolescent rats with low insular 
levels of DA exhibited depression- like behavior and increased eth-
anol intake (Ruiz et al., 2017). It is, however, difficult to draw a di-
rect relationship between the dopaminergic deficit and the greater 
ethanol intake found in the males of Experiment 2a. On one hand, 
the studies by Feltmann et al. and Heinz et al. were conducted in 
rats and humans with a long history of ethanol exposure. Also, in 
Experiment 2b, the AMPH- induced reduction in insular DA was 
also found in females, yet they did not show alterations in ethanol 
intake.
The results of Experiment 2b, nonetheless, are consistent with a 
plethora of studies indicating that chronic treatment with AMPH can 
alter the functioning of the dopaminergic system. DA release in the 
lateral septum was found to be reduced in adult rats daily injected 
AMPH (2.5 mg/kg for 14 days; Renard, Sotomayor- Zarate, Blanco, 
& Gysling, 2014), and earlier work indicated DA depletion and loss 
of receptors in the dorsal striatum (Krasnova et al., 2001; Wagner, 
Ricaurte,	Johanson,	Schuster,	&	Seiden,	1980)	and	in	the	olfactory	
bulb (Atianjoh, Ladenheim, Krasnova, & Cadet, 2008), after repeated 
AMPH treatment. It is interesting to remark that termination of a 
6- day AMPH exposure to rats (5.0 or 10.0 mg kg−1 day−1) has been 
associated with depressive- like behavior and deficits in brain re-
ward function, as indicated by increased intracranial self- stimulation 
(Cryan et al., 2003). Also, repeated exposure to AMPH or MPH has 
been used to induce psychotic- like states (Frey et al., 2006). We did 
not measure these variables, yet we cannot discard that similar alter-
ations may have emerged in our study. Also important is that the ex-
perimental design did not include subjects outside of the adolescent 
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period, and thus, it cannot be concluded that the pattern found is an 
age- specific, developmental effect.
The present results should be considered in the context of im-
portant limitations. A single MPH dose and AMPH dose were used 
across experiments. This precludes assessing graded, dose- response 
effects and, moreover, the doses employed are in the upper range 
of those commonly employed in the literature and significantly be-
yond those dispensed orally to children affected by ADHD [for a 
discussion on which combination of dose, route of administration 
and interval between administration better mimics in rodents the 
treatment used in humans, please see Kuczenski and Segal (2001)]. 
There are also between- experiments methodological changes that 
complicate the comparisons and interpretation of the results.
Another important limitation is that the MPH and AMPH doses 
employed were not equated for their level of drug- induced motor 
stimulation. Moreover, the dose of amphetamine use in Experiment 
2 induces stereotypy (Salisbury & Wolgin, 1985; Wolgin, 2012), yet 
the method of analyzing motor stimulation employed (photocell 
beam breaks) does not allow measurement of stereotypy. It is pos-
sible, thus, that the measures of amphetamine- induced locomotion 
were confounded, and probably reduced, by this drug increasing 
stereotypy. Moreover, a very limited monoamine analysis was con-
ducted (i.e., only the insular levels were addressed). The rationale 
was that studies from our laboratory (Ruiz et al., 2017) and from 
others [e.g., (Diaz Heijtz & Castellanos, 2006) have suggested an as-
sociation between neural activity or DA levels at this structure and 
ethanol intake or stimulant- induced behavioral activity.
Despite these limitations, the main contribution of the study is 
that a short treatment with AMPH during adolescence, subthreshold 
in terms of inducing behavioral sensitization, can significantly alter 
dopamine levels in the insula in male and females, and enhances eth-
anol intake and preference in males. Chronic exposure to MPH did 
not ostensibly affect these outcomes.
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